Uncategorized


March 13, 2026

Trade Potpourri: Sec. 301, Court Challenge to Sec. 122 Tariffs, U.S.-China Trade and the USMCA

By Joe Lieber

There is a lot happening on the trade front from 60 Section 301 tariff country investigations announced by the Trump administration yesterday, to court dates set in the Section 122 legal challenge, and the ongoing USMCA saga. Taken together, these issues are likely to…

Read More >>

March 13, 2026

Amazon (AMZN) Satellite Waiver: FCC Relief Likely Despite Carr’s Comments on Deployment Shortfall

By Joe Lieber

Amazon’s (AMZN) request for additional time to meet its Project Kuiper deployment timeframe has attracted renewed scrutiny from the FCC, given recent comments from FCC Chairman Brendan Carr—including a post on X this week criticizing the company’s opposition to SpaceX’s satellite expansion and…

Read More >>

March 12, 2026

Hospitals: Latest CMS Batch of Approved Hospital-Specific DPPs [HCA, THC, UHS]

By Beth Steindecker

CMS’s latest approvals for hospital-specific Medicaid state directed payment programs (DPPs) provide incremental positive news for HCA, THC and UHS due to their footprint in certain states (Georgia, Michigan, Kentucky, and Nevada) where CMS recently…

Read More >>

March 10, 2026

GKOS: Less Sanguine on iDose Coverage Questions

By John Leppard

Despite recent speculation that Medicare Administrative Contractors (MACs) may not pursue a formal coverage policy for GKOS iDose procedures, we continue to expect a draft local coverage determination (LCD) in Q2 / Q3. Following the…

Read More >>

March 10, 2026

Medicaid Expansion Levels – Thoughts on Potential 2027 Enrollment Declines [MOH, CNC, ELV]

By Beth Steindecker

With Medicaid insurers [MOH, CNC, ELV] projecting more muted Medicaid enrollment changes for 2026 compared with the sizable attrition during the post-pandemic Medicaid unwinding – and little guidance on what comes next – investors are…

Read More >>

March 9, 2026

Capitol Policy Weekly: Iran Pressures Markets, Housing Advances, Trade Tensions Return

By Joe Lieber

With Congress partially out of session this week, Washington will continue to revolve around the Iran conflict, trade policy adjustments, and a handful of legislative initiatives moving through the Senate. The Senate remains in session while the…

Read More >>

March 9, 2026

[LNTH] Pylarify 2.0 Payment Pathway

By John Leppard

Following FDA approval of LNTH’s Pylarify TruVu late Friday, we continue to expect CMS to provide a three-year transitional pass-through (TPT) payment for hospital outpatient services effective Oct. 1, 2026, with our best estimate on…

Read More >>

March 6, 2026

[INSP, LIVN, NYXH] New Hypoglossal Code By 2028

By John Leppard

As we had anticipated, the American Medical Association’s (AMA) CPT Editorial Panel will evaluate the creation of a new reimbursement code to describe single lead hypoglossal nerve neurostimulation (HGNS) devices (e.g., INSP’s Inspire V) at…

Read More >>

March 2, 2026

CMS’s ELV Sanction Warnings Sends MA Risk Adjustment Message, But Does It Up the Ante on a Broader Crackdown?

By Beth Steindecker

CMS’s warning letter against ELV of potential sanctions on new Medicare Advantage (MA) enrollment underscores another enforcement lever the agency can deploy to curb improper risk adjustment behaviors and overpayments. As the agency remains committed…

Read More >>

March 2, 2026

Capitol Policy Weekly: Iran Dominates, Housing Moves, Farm Bill Marks Up, Texas Votes

By Joe Lieber

With the Congress back in Washington this week, Iran will dominate the agenda, but it won’t completely crowd out housing policy, Department of Homeland Security (DHS) funding, and Farm Bill politics.  The House and Senate are both expected to move an Iran-related war powers resolution this week; however, it is unlikely to constrain the…

Read More >>